The Motley Fool·1 day ago
Prediction: Intuitive Surgical Will Be Worth $500 Billion by 2031 -- Here's WhyIntuitive Surgical is a robotic surgery giant and has delivered a track record of growth. The company's revenue has doubled over five years.
Intuitive Surgical, Inc.(ISRG)Earnings, Financials & Key Ratios
ISRG•NASDAQ
$432.83
55.0× P/E·Price updated Jul 6, 2026
AboutIntuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.Show more
- Revenue$10.06B+20.5%
- EBITDA$3.62B+28.9%
- Net Income$2.86B+23.0%
- EPS (Diluted)7.87+22.6%
- Gross Margin66%-2.2%
- EBITDA Margin35.99%+6.9%
- Operating Margin29.27%+4.1%
- Net Margin28.38%+2.0%
- ROE16.57%+6.8%
ISRG Price & Volume
Intuitive Surgical, Inc. (ISRG) stock price & volume — 10-year historical chart
Loading chart...
Recurring Revenue Growth Drives Robust Margin Expansion
Investment Thesis • Updated 2026Q1
VerdictPositive
Growth:Accelerating
Profitability:Strong
Financial:Fortress
Cash Flow:Robust
Primary Risk:Procedure volume saturation risk
Key Thesis Takeaways
- Intuitive Surgical demonstrates a compelling growth trajectory underpinned by a 23.0% year-over-year revenue increase in 2026Q1 and a resilient 66.1% gross margin profile.
- While the company maintains a fortress balance sheet with a 17.36 current ratio, investors should monitor the potential for margin volatility as the firm transitions its installed base to newer hardware platforms.
- Long-term value creation appears supported by disciplined capital allocation, evidenced by $1.1 billion in share repurchases during the most recent quarter.
Verdict Logic
the company's ability to generate $808.6 million in free cash flow during 2026Q1 while maintaining a 29.2% FCF margin justifies its premium valuation despite the 51.37 P/E ratio.
ISRG Growth Metrics
Intuitive Surgical, Inc. (ISRG) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years15.49%
5 Years18.22%
3 Years17.39%
TTM21.43%
Profit CAGR
10 Years17.11%
5 Years21.91%
3 Years29.26%
TTM20.31%
EPS CAGR
10 Years16.36%
5 Years21.77%
3 Years29.19%
TTM20.97%
Return on Capital
10 Years16.27%
5 Years14.99%
3 Years15.22%
Last Year16.49%
ISRG Recent Earnings
Intuitive Surgical, Inc. (ISRG) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 12/12 qtrs (100%)●Beat Revenue 11/12 qtrs (92%)
Q2 2026Latest
Apr 21, 2026Metric
Actual
Est
EPS
$2.50+17.9%
$2.12
Rev
$2.8B+5.8%
$2.6B
Q1 2026
Jan 22, 2026Metric
Actual
Est
EPS
$2.53+11.5%
$2.27
Rev
$2.9B+3.7%
$2.8B
Q4 2025
Oct 21, 2025Metric
Actual
Est
EPS
$2.40+20.6%
$1.99
Rev
$2.5B+4.1%
$2.4B
Q3 2025
Jul 22, 2025Metric
Actual
Est
EPS
$2.19+13.5%
$1.93
Rev
$2.4B+3.8%
$2.4B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 21, 2026 | $2.50vs $2.12+17.9% | $2.8Bvs $2.6B+5.8% |
| Q1 2026 | Jan 22, 2026 | $2.53vs $2.27+11.5% | $2.9Bvs $2.8B+3.7% |
| Q4 2025 | Oct 21, 2025 | $2.40vs $1.99+20.6% | $2.5Bvs $2.4B+4.1% |
| Q3 2025 | Jul 22, 2025 | $2.19vs $1.93+13.5% | $2.4Bvs $2.4B+3.8% |
Based on last 12 quarters of dataView full earnings history →
Latest ISRG News
Recent stock market news and headlines for Intuitive Surgical, Inc. (ISRG)
Zacks Investment Research·1 day ago
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should KnowRecently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
The Motley Fool·4 days ago
Intuitive Surgical Is Down 28%, and Wall Street Is Piling On. Goldman Sachs Just Said Everyone Is Wrong -- and History Is on Its Side.Intuitive Surgical is extending the lifetimes of some of its instruments. Revenue surged 23% year over year in the first quarter.
Zacks Investment Research·5 days ago
Why Intuitive Surgical (ISRG) Could Beat Earnings Estimates AgainIntuitive Surgical (ISRG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Motley Fool·5 days ago
Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026?Abbott Laboratories offers a highly diversified revenue stream across medical devices, diagnostics, nutrition, and generic medicines. Intuitive Surgical maintains a dominant position in robotic-assisted surgery with a high-margin, recurring revenue business model.
Peers Comparison
Key metrics vs top competitors for Intuitive Surgical, Inc. (ISRG)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $432.83 | $153.29B | 55.00 | 20.51% | 28.38% | 16.57% | — | |
| $313.38 | $120.14B | 37.31 | 11.16% | 13.21% | 15.1% | — | |
| $83.06 | $106.64B | 22.27 | 8.43% | 13.2% | 9.78% | — | |
| $44.60 | $66.29B | 22.99 | 19.87% | 17.23% | 14.67% | — | |
| $89.76 | $17.58B | 25.28 | 7.2% | 9.05% | 5.77% | — | |
| $76.01 | $16.97B | 30.53 | 1.74% | 13.18% | 11.01% | — |
Compare ISRG vs Peers
Intuitive Surgical, Inc. (ISRG) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ISRG SEC Filings & Documents
Intuitive Surgical, Inc. (ISRG) SEC filings — annual & quarterly reports (10-K, 10-Q)
8-K Announcements
6Material company update
May 28, 2026·SEC
Material company update
May 4, 2026·SEC
Material company update
Apr 21, 2026·SEC
10-K Annual Reports
210-Q Quarterly Reports
6Get notified when ISRG posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
ISRG Frequently Asked Questions
Intuitive Surgical, Inc. (ISRG) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Intuitive Surgical, Inc.'s revenue?
Intuitive Surgical, Inc. (ISRG) reported $10.58B in revenue for fiscal year 2025. This represents a 103728% increase from $10.2M in 1999.
How fast is Intuitive Surgical, Inc. growing?
Intuitive Surgical, Inc. (ISRG) grew revenue by 20.5% over the past year. This is strong growth.
Is ISRG profitable?
Yes, Intuitive Surgical, Inc. (ISRG) is profitable, generating $2.98B in net income for fiscal year 2025 (28.4% net margin).
Dividend & Returns
What is ISRG's return on equity?
Intuitive Surgical, Inc. (ISRG) has a return on equity (ROE) of 16.6%. This is reasonable for most industries.
What is Intuitive Surgical, Inc.'s free cash flow?
Intuitive Surgical, Inc. (ISRG) generated $2.83B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.